insights_auto
Kwa nini ALMKT imepungua kwa 2.79%?
Fahamu zaidichevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€ 0.087
arrow_downward
-2.79%(-0.0025) Siku 1
20 Nov, 17:35:11 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.09
Juu
€ 0.09
Chini
€ 0.09
Mtaji wa soko
16.66M
Wastani wa kiasi cha mauzo
elfu 406.96
Kiasi cha mauzo ya hisa
elfu 258.62
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.74
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.09
Juu
€ 0.09
Chini
€ 0.09
Mtaji wa soko
16.66M
Wastani wa kiasi cha mauzo
elfu 406.96
Kiasi cha mauzo ya hisa
elfu 258.62
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.74
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Beinsure
·
dakika 43 zilizopita
Nasdaq Composite record highs in 2026 raise concerns over AI stock valuations
The Motley Fool
·
saa 6 zilizopita
The S&P 500 Just Whipsawed Near a Record High. Here’s Why I’m Lowering My Expectations, Not Selling.
24/7 Wall St.
·
saa 5 zilizopita
Billionaire Ray Dalio's Bridgewater Keeps 16% of Its $23 Billion Stock Portfolio in S&P 500 Index Funds, Even After Cutting Them
Benzinga
·
siku 1 iliyopita
Four S&P 500 Stocks Rising in a Falling Market: Pentair, AppLovin, Chipotle, and Gen Digital
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com